ACADIA Pharmaceuticals
ACAD
#3644
Rank
$2.56 B
Marketcap
$15.38
Share price
-4.59%
Change (1 day)
-16.50%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): $0.25 Billion USD

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are $0.95 Billion USD. , an increase over its 2023 earnings that were of -$51.04 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 $0.25 B-605.67%
2023 -$51.04 Million-76.09%
2022 -$0.22 Billion27.41%
2021 -$0.17 Billion-40.38%
2020 -$0.29 Billion19.88%
2019 -$0.24 Billion-3.92%
2018 -$0.25 Billion-15.04%
2017 -$0.29 Billion6.33%
2016 -$0.28 Billion64.55%
2015 -$0.17 Billion77.47%
2014 -$92.48 Million143.69%
2013 -$37.95 Million81.93%
2012 -$20.86 Million-8.73%
2011 -$22.86 Million-251.39%
2010 $15.09 M-133.2%
2009 -$45.47 Million-30.82%
2008 -$65.73 Million6.43%
2007 -$61.76 Million25.89%
2006 -$49.06 Million36.99%
2005 -$35.81 Million37.22%
2004 -$26.1 Million19.96%
2003 -$21.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$40.66 Million-115.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.11 B 4,206.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.68 B 4,813.46%๐Ÿ‡บ๐Ÿ‡ธ USA
$17.44 B 6,658.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.38 Billion-3,346.73%๐Ÿ‡บ๐Ÿ‡ธ USA
-$38.63 Million-114.97%๐Ÿ‡บ๐Ÿ‡ธ USA